Common risks shared with all GLP-1 medications include gastrointestinal side effects - nausea, vomiting, diarrhea, constipation - especially when starting or increasing dose
When administered as once-weekly injections, these drugs assist patients in feeling full longer and eating less
Often, healthcare providers evaluate the best approach based on individual health status, weight loss goals, and preferences
It mimics not just one but two hormones: GLP-1 and GIP
Dulaglutide: Moderate Weight Loss The pharmaceutical product Dulaglutide, marketed as Trulicity, delivers modest benefits for reducing weight
Lixisenatide, a structurally modified derivative of exendin-4, addresses some of these limitations by offering a longer half-life of approximately 3 h, thereby permitting once-daily dosing (Leon et al., 2017)